Governments can set the price like they did with insulin, or just nationalize production and sell it themselves.

Yeah, but then you have packaging costs, and distribution costs, and marketing costs, and shareholder dividends, and CEO bonuses, and AI integration, and lobbying costs....

So really, we're practically losing money at a $450/month subscription.